Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine

Menactra® (Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine)

Be the first to review this product

Physician's authorization is required to purchase this item. Physician's authorization is required to purchase this item.

Menactra®, Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine, is indicated for active immunization to prevent invasive meningococcal disease caused by N meningitidis serogroups A, C, Y and W-135. Menactra is approved for use in individuals 9 months through 55 years of age. Menactra vaccine does not prevent N meningitidis serogroup B disease.

Item Name Menactra® (Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine)
Specifications No
Brand Sanofi Pasteur
HCPCS No
Free Shipping No
Warning

Physician's authorization is required to purchase this item. Physician's authorization is required to purchase this item.

User Manual N/A
Brochure N/A
MSDS N/A
OR
SKU Image Item Name PKG Availability Price Qty
49281-589-05 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine 1/VL

Usually in Stock - Ships within 24 Hours

$149.95